Internal Medicine, Endocrinology, Diabetes, & Metabolism · El Paso, TX
NPI
1083010060
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2270 Joe Battle Blvd Ste O
El Paso, TX, 79938
Phone (915) 856-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
2,101 services
Medicare patients, 2024
413
Average age 70
Drug cost, 2024
$7.6M
13,061 prescriptions
Company payments, 2025
$2,215
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ifeoma A Egbuonu was code 99214 (office e&m - established), 604 times for 315 patients. In total Ifeoma A Egbuonu billed 2,101 services in 17 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 604 | 315 | $84.09 | $51K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 431 | 214 | $12.09 | $5,210 |
| 82962 Clinical Chemistry | Office | 306 | 159 | $3.19 | $977 |
| 99213 Office E&M - Established | Office | 266 | 195 | $59.09 | $16K |
| 95251 Test - Miscellaneous | Office | 170 | 80 | $23.83 | $4,051 |
| 99204 Office E&M - New | Office | 74 | 74 | $115.02 | $8,511 |
| 96372 Injection Administration | Office | 54 | 14 | $9.63 | $520 |
| 99443 Telephone Services | Office | 50 | 37 | $90.66 | $4,533 |
| 83036 Blood Count | Office | 35 | 33 | $9.52 | $333 |
| 99203 Office E&M - New | Office | 33 | 33 | $72.22 | $2,383 |
| 95250 Test - Miscellaneous | Office | 31 | 19 | $103.53 | $3,209 |
| 10005 Other Organ Systems | Office | 24 | 22 | $92.10 | $2,210 |
By year: 2022 $68K for 1,311 services; 2023 $85K for 1,610 services; 2024 $100K for 2,101 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 306 | 159 | $3.19 | $977 |
| 83036 Blood Count | 35 | 33 | $9.52 | $333 |
Medicare prescription drug claims, 2024
In 2024, the drug Ifeoma A Egbuonu prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,750 prescriptions and refills. In total Ifeoma A Egbuonu wrote 13,061 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,750 | 4,666 | 582 | $88K |
| Mounjaro Tirzepatide | 698 | 1,138 | 180 | $1.2M |
| Ozempic Semaglutide | 636 | 1,272 | 228 | $1.3M |
| Atorvastatin Calcium Generic | 474 | 1,353 | 189 | $3,563 |
| Metformin Hcl Generic | 466 | 1,255 | 181 | $3,034 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 410 | 966 | 159 | $89K |
| Jardiance Empagliflozin | 312 | 740 | 108 | $428K |
| Glipizide Generic | 307 | 836 | 118 | $2,317 |
| Synthroid Levothyroxine Sodium | 297 | 675 | 92 | $28K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 284 | 602 | 106 | $332K |
| Farxiga Dapagliflozin Propanediol | 277 | 575 | 91 | $323K |
| Methimazole Generic | 268 | 440 | 68 | $1,859 |
| Tresiba Flextouch U-200 Insulin Degludec | 266 | 674 | 98 | $420K |
| Alendronate Sodium Generic | 219 | 583 | 92 | $1,183 |
| Liothyronine Sodium Generic | 214 | 514 | 70 | $244K |
Brand drugs: 6,501 claims; generic drugs: 6,029 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ifeoma A Egbuonu $2,215 ($2,215 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbott Laboratories with $356.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 17 | $356 |
| Novo Nordisk Inc NVO | 11 | $319 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 22 | $259 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 24 | $247 |
| Corcept Therapeutics CORT | 10 | $219 |
| Amgen Inc. AMGN | 12 | $141 |
| Xeris Pharmaceuticals, Inc. | 6 | $119 |
| Insulet Corporation PODD | 3 | $65.94 |
| Recordati_rare_diseases_inc. | 3 | $65.59 |
| Soleno Therapeutics, Inc. SLNO | 2 | $57.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.